Ainos signs VELDONA license deal with BioPhoenix worth up to $10 million

Bitget2026/09/24 12:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Ainos signed a VELDONA license deal with BioPhoenix, setting a conditional collaboration framework valued at up to USD 10 million.
BioPhoenix secured exclusive worldwide rights for Sjögren's disease and thrombocytopenia, covering development, manufacturing, and commercialization.
BioPhoenix will fund and run assigned clinical and regulatory work, shifting late-stage development costs away from Ainos.
Framework includes an upfront license fee, potential payments for up to 15 additional indications, and a one-time fee on BioPhoenix’s first sublicense.
Ainos will receive 25% of applicable net sublicensing revenue, separate from license fees and any product supply revenue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ainos Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609240800ACCESSWRNAPR_____1226495) on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OpenAI is racing against time—in order to secure funding ahead of rival Anthropic’s IPO, the company has significantly compressed its fundraising timeline, aiming to complete approximately $30 billion in private financing, which could push its valuation past $1.4 trillion upon completion. Major investors such as SoftBank and MGX are already engaged in discussions. Both AI giants are targeting trillion-dollar valuations, and their largely overlapping investor bases are being forced to make simultaneous bets on both ventures within just a few days.

华尔街见闻•2026/10/20 03:46

Report: OpenAI plans to accelerate fundraising before Anthropic goes public

Updated version 1 - Amid fears of being removed from MSCI and after authorities curbed the decline, Indonesia’s stock market rose slightly.

路透社•2026/10/20 03:36

Oil prices surge as the biggest boost! Marathon Petroleum (MPC.US) up over 200% this year, outperforming major chip giants; shares hit a 52-week high and remain bullish

Marathon Petroleum has performed exceptionally well this year, with its stock price surging over 200% since the beginning of the year, outpacing even leading technology companies and chip manufacturers.

智通财经•2026/10/20 03:22